The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects millions but has no medical cure.

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Reticular pseudodrusen and subretinal hyperreflective material are among the OCT findings that may predict macular atrophy in ...

OCT has been used to detect and monitor macular diseases including age-related macular degeneration ... other causes of posterior uveitis. Fundus autofluorescence (FAF) is an imaging technique ...

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

Age-related macular degeneration (AMD) has three stages: early, intermediate, and late stage. Vision loss usually happens in the last stage of AMD. However, not everyone with AMD progresses through ...

You might develop blurry vision or other trouble seeing. This could be a sign of age-related macular degeneration (AMD). Wet AMD is the advanced form of the disease. It happens when new blood ...

People who develop macular degeneration often begin experiencing symptoms after 50 years old, but symptoms can happen earlier or later depending on conditions and risk factors. Share on Pinterest ...

Opens in a new tab or window Obstructive sleep apnea (OSA) was linked to a more than twofold risk of developing age-related macular degeneration (AMD) in a retrospective cohort study. Among 58,700 ...